These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 23340202

  • 1. VI nerve palsy after intravenous immunoglobulin in Kawasaki disease.
    Rodríguez-Lozano A, Juárez-Echenique JC, Rivas-Larrauri F, Gámez-González LB, Yamazaki-Nakashimada M.
    Allergol Immunopathol (Madr); 2014; 42(1):82-3. PubMed ID: 23340202
    [No Abstract] [Full Text] [Related]

  • 2. Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.
    Shiraishi T, Yamamoto T.
    Pediatr Dermatol; 2013; 30(3):e30-1. PubMed ID: 22304420
    [Abstract] [Full Text] [Related]

  • 3. Abducens nerve palsy in a girl with incomplete Kawasaki disease.
    Emiroglu M, Alkan G, Kartal A, Cimen D.
    Rheumatol Int; 2016 Aug; 36(8):1181-3. PubMed ID: 27329470
    [Abstract] [Full Text] [Related]

  • 4. Patient characteristics and intravenous immunoglobulin product may affect eosinophils in Kawasaki disease.
    Kuo HC, Wang CL, Wang L, Yu HR, Yang KD.
    Pediatr Allergy Immunol; 2008 Mar; 19(2):184-5. PubMed ID: 18257906
    [No Abstract] [Full Text] [Related]

  • 5. Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.
    Khan S, Doré PC, Sewell WA.
    Pediatr Allergy Immunol; 2008 Mar; 19(2):186-7. PubMed ID: 18257907
    [No Abstract] [Full Text] [Related]

  • 6. Isolated abducens palsy in adolescent girl with Kawasaki disease.
    Guven B, Tavli V, Mese T, Yilmazer MM, Aydogan M.
    Pediatr Int; 2010 Apr; 52(2):334. PubMed ID: 20500489
    [No Abstract] [Full Text] [Related]

  • 7. Reduced serologic response to mumps, measles, and rubella vaccination in patients treated with intravenous immunoglobulin for Kawasaki disease.
    Tacke CE, Smits GP, van der Klis FR, Kuipers IM, Zaaijer HL, Kuijpers TW.
    J Allergy Clin Immunol; 2013 Jun; 131(6):1701-3. PubMed ID: 23498596
    [No Abstract] [Full Text] [Related]

  • 8. Recommendations for intravenous immunoglobulin therapy of Kawasaki disease.
    Shulman ST.
    Pediatr Infect Dis J; 1992 Nov; 11(11):985-6. PubMed ID: 1454455
    [No Abstract] [Full Text] [Related]

  • 9. Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation.
    Wright SE, Shaikh ZH, Castillo-Lugo JA, Tanriover B.
    Transpl Infect Dis; 2008 Jul; 10(4):294-7. PubMed ID: 18086279
    [Abstract] [Full Text] [Related]

  • 10. Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease.
    Wada Y, Kamei A, Fujii Y, Ishikawa K, Chida S.
    J Pediatr; 2006 Mar; 148(3):399-400. PubMed ID: 16615977
    [Abstract] [Full Text] [Related]

  • 11. Acute aseptic meningitis secondary to intravenous immunoglobulin in a patient with Kawasaki syndrome.
    Boyce TG, Spearman P.
    Pediatr Infect Dis J; 1998 Nov; 17(11):1054-6. PubMed ID: 9849996
    [No Abstract] [Full Text] [Related]

  • 12. Adult Kawasaki disease: evaluating the fluctuation of circulating lymphocytes associated with i.v. immunoglobulin treatment.
    Fujimoto N, Teramura K, Tanaka T.
    J Dermatol; 2012 Nov; 39(11):957-8. PubMed ID: 22390144
    [No Abstract] [Full Text] [Related]

  • 13. Intravenous immune globulin use in children.
    Tyrrell MJ.
    CMAJ; 1992 Jun 15; 146(12):2140. PubMed ID: 1611567
    [No Abstract] [Full Text] [Related]

  • 14. Lateral rectus palsy in Kawasaki disease.
    Wurzburger BJ, Avner JR.
    Pediatr Infect Dis J; 1999 Nov 15; 18(11):1029-31. PubMed ID: 10571450
    [No Abstract] [Full Text] [Related]

  • 15. [Aseptic meningitis secondary to intravenous immunoglobulin treatment in Kawasaki disease].
    García Norniella B, Morán Poladura M, Fernández Díaz M, Fernández Fernández E, Suárez Castañón C.
    An Pediatr (Barc); 2011 Jul 15; 75(1):79-80. PubMed ID: 21420919
    [No Abstract] [Full Text] [Related]

  • 16. Changes in BAFF/APRIL levels in a 2-year-old girl with Kawasaki disease refractory to intravenous immunoglobulin therapy.
    Yoshida S, Sakurai Y, Takeda T, Fukuda K.
    J Investig Allergol Clin Immunol; 2013 Jul 15; 23(1):52-3. PubMed ID: 23653975
    [No Abstract] [Full Text] [Related]

  • 17. Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease.
    Shrestha S, Wiener HW, Olson AK, Edberg JC, Bowles NE, Patel H, Portman MA.
    J Allergy Clin Immunol; 2011 Sep 15; 128(3):677-80. PubMed ID: 21601260
    [Abstract] [Full Text] [Related]

  • 18. Facial palsy in Kawasaki syndrome.
    Bushara K, Wilson A, Rust RS.
    Pediatr Neurol; 1997 Nov 15; 17(4):362-4. PubMed ID: 9436804
    [Abstract] [Full Text] [Related]

  • 19. Kawasaki-like syndrome possibly associated with immune reconstitution inflammatory syndrome in an HIV-positive patient.
    Velez AP, Menezes L, Crespo A.
    AIDS Read; 2006 Sep 15; 16(9):464-6. PubMed ID: 17024765
    [Abstract] [Full Text] [Related]

  • 20. A child with prolonged pyrexia and peripheral desquamation: is it Kawasaki disease?
    Mitra S, Singh S, Grover A, Kumar L.
    Indian Pediatr; 2000 Jul 15; 37(7):786-9. PubMed ID: 10906815
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.